Hyperhomocysteinemia: an independent risk factor for vascular disease
- PMID: 2011158
- DOI: 10.1056/NEJM199104253241701
Hyperhomocysteinemia: an independent risk factor for vascular disease
Abstract
Background: Hyperhomocysteinemia arising from impaired methionine metabolism, probably usually due to a deficiency of cystathionine beta-synthase, is associated with premature cerebral, peripheral, and possibly coronary vascular disease. Both the strength of this association and its independence of other risk factors for cardiovascular disease are uncertain. We studied the extent to which the association could be explained by heterozygous cystathionine beta-synthase deficiency.
Methods: We first established a diagnostic criterion for hyperhomocysteinemia by comparing peak serum levels of homocysteine after a standard methionine-loading test in 25 obligate heterozygotes with respect to cystathionine beta-synthase deficiency (whose children were known to be homozygous for homocystinuria due to this enzyme defect) with the levels in 27 unrelated age- and sex-matched normal subjects. A level of 24.0 mumol per liter or more was 92 percent sensitive and 100 percent specific in distinguishing the two groups. The peak serum homocysteine levels in these normal subjects were then compared with those in 123 patients whose vascular disease had been diagnosed before they were 55 years of age.
Results: Hyperhomocysteinemia was detected in 16 of 38 patients with cerebrovascular disease (42 percent), 7 of 25 with peripheral vascular disease (28 percent), and 18 of 60 with coronary vascular disease (30 percent), but in none of the 27 normal subjects. After adjustment for the effects of conventional risk factors, the lower 95 percent confidence limit for the odds ratio for vascular disease among the patients with hyperhomocysteinemia, as compared with the normal subjects, was 3.2. The geometric-mean peak serum homocysteine level was 1.33 times higher in the patients with vascular disease than in the normal subjects (P = 0.002). The presence of cystathionine beta-synthase deficiency was confirmed in 18 of 23 patients with vascular disease who had hyperhomocysteinemia.
Conclusions: Hyperhomocysteinemia is an independent risk factor for vascular disease, including coronary disease, and in most instances is probably due to cystathionine beta-synthase deficiency.
Comment in
-
Homocysteinemia: a risk factor for vascular disease.N Engl J Med. 1991 Sep 26;325(13):966-7. N Engl J Med. 1991. PMID: 1881423 No abstract available.
Similar articles
-
Heterozygous carriers of classical homocystinuria tend to have higher fasting serum homocysteine concentrations than non-carriers in the presence of folate deficiency.Clin Nutr. 2015 Dec;34(6):1155-8. doi: 10.1016/j.clnu.2014.11.013. Epub 2014 Dec 3. Clin Nutr. 2015. PMID: 25516282
-
[Hyperhomocysteinemia: an independent risk factor or a simple marker of vascular disease?. 1. Basic data].Pathol Biol (Paris). 2003 Mar;51(2):101-10. doi: 10.1016/s0369-8114(03)00104-4. Pathol Biol (Paris). 2003. PMID: 12801808 Review. French.
-
Vascular complications of severe hyperhomocysteinemia in patients with homocystinuria due to cystathionine beta-synthase deficiency: effects of homocysteine-lowering therapy.Semin Thromb Hemost. 2000;26(3):335-40. doi: 10.1055/s-2000-8100. Semin Thromb Hemost. 2000. PMID: 11011851 Review.
-
Improved identification of heterozygotes for homocystinuria due to cystathionine synthase deficiency by the combination of methionine loading and enzyme determination in cultured fibroblasts.Hum Genet. 1985;69(2):164-9. doi: 10.1007/BF00293290. Hum Genet. 1985. PMID: 3972418
-
Hyperhomocysteinaemia: a risk factor for extracranial carotid artery atherosclerosis.Ir J Med Sci. 1992 Mar;161(3):61-5. doi: 10.1007/BF02983714. Ir J Med Sci. 1992. PMID: 1517057
Cited by
-
CARDIOVASCULAR RISK IN WOMEN WITH PREECLAMPSIA.Acta Clin Croat. 2022 Dec;61(4):574-580. doi: 10.20471/acc.2022.61.04.02. Acta Clin Croat. 2022. PMID: 37868169 Free PMC article.
-
Application of homocysteine as a non-invasive and effort-free measurements for risk assessment of patients with pulmonary hypertension.Cardiol J. 2024;31(2):285-299. doi: 10.5603/cj.92813. Epub 2023 Sep 29. Cardiol J. 2024. PMID: 37772357 Free PMC article.
-
Hyperhomocysteinaemia Promotes Doxorubicin-Induced Cardiotoxicity in Mice.Pharmaceuticals (Basel). 2023 Aug 28;16(9):1212. doi: 10.3390/ph16091212. Pharmaceuticals (Basel). 2023. PMID: 37765020 Free PMC article.
-
Plasma cystine/methionine ratio is associated with left ventricular diastolic function in patients with heart disease.Heart Vessels. 2023 Dec;38(12):1422-1430. doi: 10.1007/s00380-023-02302-4. Epub 2023 Aug 24. Heart Vessels. 2023. PMID: 37620665
-
Autophagy in homocysteine‑induced HUVEC senescence.Exp Ther Med. 2023 May 31;26(1):354. doi: 10.3892/etm.2023.12053. eCollection 2023 Jul. Exp Ther Med. 2023. PMID: 37324509 Free PMC article.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical